Skip to content

Studying the effect of date pollen on sexual function and satisfaction of postmenopausal women

Studying the effect of date pollen on sexual function and satisfaction of postmenopausal women: A double-blind clinical trial study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241204063940N1
Enrollment
130
Registered
2025-06-22
Start date
2025-06-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Sexual function. Condition 2: Sexual satisfaction.

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 55 Years

Inclusion criteria

Inclusion criteria: Informed consent to participate in the study Age 45-55 years Women with natural menopause No history of sexual dysfunction in the person's past Lack of sexual dysfunction in the sexual partner (spouse with high and average sexual function (score above 25) Absence of psychological problems (depression and anxiety, as confirmed by the patient's psychiatrist) Absence of known systemic diseases affecting sexual function (breast and uterine cancers, abnormal vaginal bleeding) Not using medications that affect sexual function No hormone replacement therapy (progesterone, estrogen, gonadotropin-releasing hormone agonists and antagonists) within the last 6 months No history of pelvic surgery (colporrhaphy, reconstructive) Insensitivity to plant pollen and medicinal herbs Not using complementary medicine or specific herbal medicine within the last month to improve menopausal symptoms No history of chemotherapy or radiation therapy to the pelvis or whole body No smoking, alcohol, or drugs. Not taking blood thinners such as warfarin

Exclusion criteria

Exclusion criteria: Lack of cooperation in research Allergy to the prescribed medication Taking any other medication affecting sexual activity during the study Unexpected events such as the loss of loved ones during the study or the death of the individual Not taking the medication for 2 consecutive days or 5 alternating days Failure to complete questionnaires

Design outcomes

Primary

MeasureTime frame
Sexual function. Timepoint: Before the start of the intervention, one month and two months after the start of the intervention. Method of measurement: Women's Sexual Function Questionnaire (Rosen et al.).;Sexual satisfaction. Timepoint: Before the start of the intervention, one month and two months after the start of the intervention. Method of measurement: Sexual Satisfaction Questionnaire (Larson).

Secondary

MeasureTime frame
Sexual experience. Timepoint: Before the start of the intervention, one month and two months after the start of the intervention. Method of measurement: Arizona Sexual Experiences Questionnaire.;Quality of sex life. Timepoint: Before the start of the intervention, one month and two months after the start of the intervention. Method of measurement: Women's Sexual Quality of Life Questionnaire by Simond et al.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatima Aali

Shahre-kord University of Medical Sciences

fatiaali917@gmail.com+98 38 3333 3815

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026